Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy-Reference-Cited by-同舟云学术

Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy

Published:2016-09-08 Issue:4 Volume:44 Page:e70-e70
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Narahira Atsushi¹,Yanagi Teruki¹,Cho Kyu Yong²,Nakamura Akinobu²,Miyoshi Hideaki²,Hata Hiroo¹,Imafuku Keisuke¹,Kitamura Shinya¹,Shimizu Hiroshi¹

Affiliation:

1. Department of Dermatology; Hokkaido University Graduate School of Medicine; Sapporo Japan

2. Division of Rheumatology, Endocrinology and Nephrology; Hokkaido University Graduate School of Medicine; Sapporo Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13571/fullpdf

Reference5 articles.

1. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

2. Neurological symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review;Goto;BMC Endocr Disord,2016

3. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse event and association with outcomes;Freeman-Keller;Clin Cancer Res,2015

4. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015

5. Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma;Kähler;J Dtsch Dermatol Ges,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolated autoimmune adrenocorticotropic hormone deficiency: A positive predictor of survival among cancer patients treated with checkpoint inhibitors;Autoimmunity Reviews;2023-09

2. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review;BMC Endocrine Disorders;2022-09-24

3. Late-onset toxicities of monoclonal antibodies in cancer patients;Immunotherapy;2022-09

4. Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab;Case Reports in Dermatology;2022-03-21

5. Abdominal pain as an initial symptom of isolated ACTH deficiency induced by nivolumab in a patient with malignant mesothelioma;BMJ Case Reports;2021-07